As of 2025-07-14, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 0.49 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -5.04 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 7.2x | 5.8x |
| Forward P/E multiples | 1.1x - 2.3x | 1.7x |
| Fair Price | (0.18) - (0.09) | (0.15) |
| Upside | -1874.7% - -1012.9% | -1614.9% |
| Date | EV/EBITDA |
| 2025-07-07 | -0.10 |
| 2025-06-27 | -0.10 |
| 2025-05-16 | -0.10 |
| 2025-05-06 | -0.10 |